Salesforce to buy data visualization company Tableau for $15.7 billion
By Akshay Kedari  Date: 2019-06-11

Salesforce to buy data visualization company Tableau for $15.7 billion

Salesforce, the cloud-based software company, recently announced its plans to acquire data visualization firm Tableau Software for $15.7 billion. The acquisition is expected through an all-stock transaction, in which Tableau’s class A & class B stocks will be exchanged for 1.103 shares of Salesforce common stock, report sources.

Marc Benioff, Chairman & co-CEO, Salesforce, was reportedly quoted saying that with the new venture, the company is bringing together a world-class CRM with a top analytics platform. Tableau assists users to understand data while Salesforce assists in engaging and understanding customers. This unification of the two platforms is aimed at catering to the needs of customers, he added.

As per credible sources, Salesforce has been leading player in CRM (Customer Relationship Management) operations for years. The decision to acquire a data visualization specialist & analytics platform with over 86,000 clients worldwide signals the company’s shift into analytics field & expanding beyond its main CRM product line.

Salesforce said in a statement that with the acquisition, the company is expected to play a crucial part in driving digital transformation and allow companies world-wide to tap data across their businesses, for making smarter decisions.

Followed by the deal, Tableau will become part of Salesforce, but the company will still operate independently under the brand of Tableau. Adam Selipsky, President & CEO of Tableau, will continue to lead the firm in Washington, cite sources.

As per sources close to the matter, the acquisition will strengthen Salesforce’s revenue in the 2020 financial year by $350-$400 million, increasing GAAP revenue between $16.45 billion-$16.65 billion. Financial year 2020 non-GAAP diluted EPS (earnings per share) is expected to decrease to $0.39. The non-GAAP earnings per share is expected to reach between $2.51-$2.53.

The transaction has been approved by board of directors of Tableau and Salesforce. The transaction is expected to close during third quarter of Salesforce in 2019 and is subject to regulatory approvals.

Source credits : https://www.zdnet.com/article/salesforce-acquires-tableau-software-in-15-7-billion-deal/

About Author

Akshay Kedari    

Akshay Kedari

A qualified computer engineering graduate, Akshay Kedari takes pride in having his way with words. Following his passion for content creation, he writes insightful pieces on aeresearch.net and a few other portals. Also endorsed with a short-term experience in web deve...

Read More

More News By Akshay Kedari

Fibonacci Brands acquires Darwin from Harvest Health & Recreation
Fibonacci Brands acquires Darwin from Harvest Health & Recreation
By Akshay Kedari

Fibonacci Brands has recently announced the acquisition of Darwin from Harvest Health & Recreation (HARV.CN) as its foundation brand. Fibonacci is a leading player in the international cannabis industry. According to James George, founder of Fib...

GVN adds EVIT Center and Chumakov as its new Centers of Excellence
GVN adds EVIT Center and Chumakov as its new Centers of Excellence
By Akshay Kedari

The Global Virus Network (GVN), an international coalition of medical virologists, has recently announced the addition of Australian and Russian researchers. GVN is adding the Center for EVIT (Emerging Viruses, Inflammation & Therapeutics) of th...

Wind Point Partners takes over RTIC to expand business portfolio
Wind Point Partners takes over RTIC to expand business portfolio
By Akshay Kedari

American private equity firm, Wind Point Partners has recently signed an acquisition deal with the one of the biggest direct-to-consumer (D2C) eCommerce providers of drinkware, RTIC. Reportedly, RTIC is Wind Point’s third acquisition of a famil...

Novartis reveals positive data from Phase III ORION trials of inclisiran
Novartis reveals positive data from Phase III ORION trials of inclisiran
By Akshay Kedari

Swiss multinational pharmaceutical firm, Novartis has recently announced results from its Phase III ORION-10 and -11 studies that focus on assessing the individual responses of patients on lowering low-density lipoprotein cholesterol (LDL-C) with inc...

Medtronic to acquire Companion Medical to expand diabetes business
Medtronic to acquire Companion Medical to expand diabetes business
By Akshay Kedari

Medtronic plc, the global leader in medical technologies, has reportedly announced that it is planning to acquire insulin pen manufacturer Companion Medical. The acquisition gives Medtronic access to Companion Medical’s ‘InPen’, wh...